Objective-To examine variants at the 9p21 locus in a case-control study of acute myocardial infarction (MI) in Pakistanis and to perform an updated meta-analysis of published studies in people of European ancestry. Methods and Results-A total of 1851 patients with first-ever confirmed MI and 1903 controls were genotyped for 89 tagging single-nucleotide polymorphisms at locus 9p21, including the lead variant (rs1333049) identified by the Wellcome Trust Case Control Consortium. Minor allele frequencies and extent of linkage disequilibrium observed in Pakistanis were broadly similar to those seen in Europeans. In the Pakistani study, 6 variants were associated with MI (PϽ10 Ϫ2 ) in the initial sample set, and in an additional 741 cases and 674 controls in whom further genotyping was performed for these variants. For Pakistanis, the odds ratio for MI was 1.13 (95% CI, 1.05 to 1.22; Pϭ2ϫ10 Ϫ3 ) for each copy of the C allele at rs1333049. In comparison, a meta-analysis of studies in Europeans yielded an odds ratio of 1.31 (95% CI, 1.26 to 1.37) for the same variant (Pϭ1ϫ10 Ϫ3 for heterogeneity). Meta-analyses of 23 variants, in up to 38 250 cases and 84 820 controls generally yielded higher values in Europeans than in Pakistanis. Conclusion-To our knowledge, this study provides the first demonstration that variants at the 9p21 locus are significantly associated with MI risk in Pakistanis. However, association signals at this locus were weaker in Pakistanis than those in European studies. (Arterioscler Thromb Vasc Biol. 2010;30:1467-1473.) Key Words: myocardial infarction Ⅲ 9p21 Ⅲ Pakistanis Ⅲ risk factor Ⅲ South Asia Ⅲ meta-analysis
locus associated with CAD has been identified, suggesting a regulatory role of this locus in gene expression. 6 Although associations of variants at 9p21. 3 with CAD have been established in other non-European populations (eg, East Asians), they have not been well studied in South Asians, despite this population's high risk of vascular disease. 7 To our knowledge, we report the first large-scale study of variants at the 9p21 locus in relation to risk of acute myocardial infarction (MI) in Pakistanis. This study involved 1851 patients with confirmed diagnoses of first-ever MI and 1903 control subjects from the Pakistan Risk of Myocardial Infarction Study 8 (PROMIS) . Genotyping was conducted on 89 tagging single-nucleotide polymorphisms (SNPs) at the 9p21.3 locus, including the lead variant (rs1333049) identified by the Wellcome Trust Case Control Consortium in association with CAD. 1, 2 To place our findings in context, we also report a literaturebased meta-analysis of relevant studies, encompassing information on 23 variants at the 9p21 locus in up to 38 250 CAD cases and 84 820 controls. The current meta-analysis substantially updates a previous relevant review, 5 involving data from an additional 82 117 participants and 20 additional variants.
Methods

Study Design
This article follows the reporting recommendations of STrengthening the REporting of Genetic Association studies. 9 PROMIS is a casecontrol study of acute first-ever MI in urban Pakistan. 8 Patients with MI experienced the following: (1) symptoms within 24 hours of hospital presentation, (2) typical ECG characteristics (eg, Ն1-mm ST elevation in any Ն2 contiguous limb leads or new-onset left bundle branch block), and (3) a positive troponin test result (Ͼ1 ng/mL). Controls were individuals without a history of cardiovascular disease frequencymatched to cases by sex and age in 5-year age bands, and concurrently identified in the same hospitals as the index cases by virtue of being the following: (1) visitors of patients attending the outpatient department, (2) patients attending the outpatient department for routine noncardiac complaints, or (3) non-blood-related visitors of index MI cases. Controls with recent illnesses or infections were excluded. A locally piloted and validated epidemiological questionnaire was administered to participants by medically qualified research officers that sought more than 200 items of information in relation to ethnicity, demographic characteristics, lifestyle factors (eg, tobacco and alcohol consumption, dietary intake, and physical activity), personal and family history of cardiovascular disease, and medication use. Nonfasting blood samples were drawn from each participant and centrifuged within 45 minutes of venipuncture. Samples were stored at Ϫ80°C. The study has received approval from relevant institutional review boards in each recruitment center and the Center for Non-Communicable Diseases, Karachi, Pakistan. Informed consent was obtained from all the participants (including consent to use samples in genetic, biochemical, and other analyses).
Genotyping
DNA was extracted from leukocytes using a reference phenolchloroform protocol. 8 Genotyping was performed at the Wellcome Trust Sanger Institute, Cambridge, England. To minimize any systematic biases arising from plate-or batch-specific genotyping error, genotyping plates contained a mixture of cases and controls, including negative and positive controls. A total of 1851 cases and 1903 controls were genotyped using version 1 of the Itmat Broad Care (IBC) array of Ϸ2000 candidate genes; 169 SNPs tagged the 9p21.3 locus at r 2 Ͼ0.8 and were available in the current analyses. This array used a cosmopolitan tagging approach, using information from the HapMap Caucasian (CEU), East Asian (Han Chinese and Japanese), and African (Yoruba) populations. 10 SNPs were excluded if (1) the call rate was less than 95% (2 SNPs), (2) there was evidence of departure from Hardy-Weinberg equilibrium in controls at PϽ0.05 (17 SNPs), or (3) the minor allele frequency was less than 1% (63 SNPs), with most of such omissions resulting from SNPs being relevant in Africans and monomorphic in Pakistanis. Seven individuals were excluded because self-reported sex did not match chromosomal sex status or there was evidence of cryptic relatedness or there were more than 2% missing genotypes. After such quality control, 89 SNPs remained. The 6 SNPs most significantly associated with MI risk were genotyped in a further 741 cases and 674 controls (iPLEX: Sequenom).
Statistical Analysis
Analyses involved PLINK 1.06 11 and STATA, version 10.0 (Stata-Corp). Assuming an additive model, associations with each SNP were tested fitting a logistic regression model, adjusted for age, sex, and the first 2 principal components (calculated using all 45 000 SNPs genotyped in the array, as previously described). 1, 12 Effect modification was investigated by tests of interaction in fully adjusted models. Linkage disequilibrium (LD) was assessed using Haploview, with blocks graphically identified from the LD intensity expressed in D'. 13 Haplotype association analyses were performed with THESIAS software implementing the Stochastic-EM algorithm, 14 enabling simultaneous estimation of haplotype frequencies and their effects on MI, assuming additive effects. By using a parsimonious approach, the most informative tagging SNPs were chosen for haplotype analyses that accounted for at least 85% of the haplotypic block variability. 15 To compare LD patterns in Pakistanis with those in other ethnic groups, data were downloaded from the HapMap Web site for Europeans (CEU), East Asians (Han Chinese and Japanese), and Africans (Yoruba); and drawn using Haploview. 13
Systematic Review
We sought studies reporting on associations between variants at the 9p21 locus and risk of CAD before January 2010 (supplemental *Data are given as percentage of each group unless otherwise indicated. P values come from a t test of differences between the means for continuous variables and a 2 test of independence for categorical variables. Information was only available in 5068 participants for history of MI and history of diabetes, 5041 for tobacco use, and 4509 for waist to hip ratio. All participants had information on age, sex, and ethnicity. †Data are given as mean (SD).
Figure I
; available online at http://atvb.ahajournals.org). Electronic searches, not limited to the English language, used the MEDLINE database and involved search terms related to the locus (eg, chromosome 9, CDKN2A, CDNK2B, MTAP, ANRIL, and the rs numbers of variants previously reported) and coronary artery disease (eg, coronary heart disease, myocardial infarction, atherosclerosis, and coronary stenosis). These searches were supplemented by scanning reference lists, and hand searching relevant journals. Two investigators independently extracted the following information: genotype frequencies, unadjusted additive odds ratios, ethnicity, geographical location, CAD definition, study type (eg, genomewide association or candidate replication study), genotyping platform, study design, and source of controls. Additive odds ratios were computed for each study using genotype counts and were compared with reported odds ratios, when available. For prospective cohorts, hazard ratios were assumed to approximate odds ratios. Summary odds ratios and 95% CIs for each SNP were calculated by fitting a random-effects model that included between-study heterogeneity. Heterogeneity was assessed by the I 2 statistic 16 and the Q statistic and was investigated by prespecified study-level characteristics, notably study size, case definition, study design, and genotyping platform used.
Results
Analyses in Pakistanis
As would be expected, baseline levels of conventional risk factors were significantly higher in MI cases than controls (Table 1) . Genetic similarity did not correlate strongly with self-reported ethnicity among the 8 ethnic and linguistic groups studied in PROMIS (supplemental Figure II) , and LD patterns at the 9p21 locus were similar among the 4 major Pakistani subethnicities (supplemental Figure III) . Of the 89 relevant SNPs assessed, 6 were associated with MI at PϽ10 Ϫ2 (Figure 1 and supplemental Table I ), including the lead variant (rs1333049) identified by the Wellcome Trust Case Control Consortium. 1 The odds ratios for MI with each of these 6 SNPs were Ϸ1.13 (PϽ10 Ϫ2 for each) ( Table 2 ). In the case of rs1333049, the odds ratio for MI was 1.12 (95% CI, 1.04 to 1.20; Pϭ2ϫ10 Ϫ3 ) per C allele. The odds ratios for MI were not significantly different under a range of circumstances (supplemental Figure IVA-F) , although there was limited power to evaluate potential effect modifications (eg, it was not possible to confirm or refute the possible differences noted in men and women and between ethnic groups for some SNPs). There were 5 distinct LD blocks at the 9p21 locus in Pakistanis, each having strong intrablock LD (supplemental Figure V ). All 6 variants and haplotypes associated with MI were located within block 3. By using a parsimonious model, haplotypic associations observed in block 3 could be explained by only 2 tagging SNPs (rs1412832 and rs1333049) ( Table 3) . Haplotype analyses involving these 2 tagging SNPs generated 4 haplotypes, each with a frequency greater than 2%, and the global test of association with MI was significant (Pϭ0.03). The odds ratio for MI with the AG haplotype was 0.85 (95% CI, 0.76 to 0.95; Pϭ0.003) compared with the most frequent AC haplotype.
Three SNPs (rs7865618, rs1292136, and rs7044859) located in the genomic region of block 2 have previously been reported to modulate the effect of SNP rs1333049 on the risk of MI in Europeans, with the 2 most frequent haplotypes 
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being in "yin yang." 5 To evaluate these findings in Pakistanis, we analyzed proxy SNPs (rs518394, rs10965212, and rs7049105) based on the HapMap CEU data (0.69Յr 2 Յ0.90). We did not find any significant evidence for a heterogeneous effect of the rs1333049-C allele according to the haplotypic backgrounds generated by these 3 proxy SNPs or SNP tagging block 2 (data available on request).
Meta-Analysis
We identified 26 relevant studies of 23 variants at the 9p21 locus, comprising 38 250 cases and 84 820 controls (supplemental Table II ). Nineteen studies were based in Europe or the United States, 1-5,17-30 6 in East Asia, [31] [32] [33] [34] [35] [36] and 1 in North Africa. 37 Of these studies, 5 were prospective, 17,21,25,28,30 2 were nested case-control, 22, 29 and 19 were retrospective case-control studies.
Five studies included only patients with MI, whereas 21 included patients with MI or coronary stenosis (defined by intervention procedures). Of the 23 variants studied, 21 were associated with CAD risk in Europeans and 6 with CAD risk in East Asians (Figure 2 and supplemental Figure VIA-W). For most variants, there was null to moderate heterogeneity between ethnic-specific odds ratios (eg, I 2 values typically ranged from 0% to 20%, and 6 SNPs had I 2 Ͼ50%). For Europeans and East Asians, the combined odds ratios for CAD were 1.31 (95% CI, 1.26 to 1.37; PϽ10 Ϫ35 ) and 1.25 (95% CI, 1.13 to 1.39; PϽ10 Ϫ5 ), respectively, per C allele of rs1333049. When the original GWAS report was excluded, the corresponding odds ratio was 1.29 (95% CI, 1.23 to 1.36) in Europeans. Of the 23 variants studied, data were available on 12 SNPs in PROMIS ( Figure 2) . The odds ratios for MI with variants at this locus were generally lower in Pakistanis than in European studies (eg, heterogeneity test Pϭ1ϫ10 Ϫ3 for rs1333049), although the allelic frequencies in Pakistanis and Europeans were similar ( Figure 2 ). Data from HapMap suggested a high degree of LD between rs1333049 and nearby variants at the 9p21 locus, with a similar pattern of LD in Europeans and Pakistanis (supplemental Figure VII ).
Discussion
In the first large-scale genetic study of MI in Pakistan, we investigated 89 SNPs spanning 350 kb at the 9p21.3 locus and identified 6 SNPs significantly associated with the risk of MI.
In an updated literature-based meta-analysis of 38 250 CAD cases and 84 820 controls, we confirmed associations of 21 variants at this locus with CAD in Europeans (also confirming associations of 6 variants at this locus with CAD in East Asians). We observed that the odds ratios for MI with variants at the 9p21.3 locus were generally lower (typically by about half as much) in Pakistanis than those reported in studies of people of European continental ancestry. However, as discussed later, further studies are needed to determine whether such differences are mainly related to ethnicity, study design features, or both. The LD structure in PROMIS was similar to that previously observed in Europeans (CEU) and somewhat stronger than that in East Asians (CHB) and Africans (YRI). The 6 SNPs associated with MI in PROMIS were located within 1 block that had a high intrablock LD spanning 53 kb. Two haplotype-tagging SNPs (rs1333049 and rs1412832) were sufficient to explain the observed association with MI in Pakistanis. This block partially overlapped with the region of association previously identified in Europeans. 5 In Pakistanis, we did not observe the reported significant modulation found in Europeans of the effect of rs1333049 on MI by either proxy or tag SNPs of haplotype block 2 5 ; this null finding may have been the result of limited statistical power and/or inadequate proxy markers in the Pakistani study.
For Pakistanis, Europeans, and East Asians, analyses of the present data and HapMap indicated that CAD-related variants at the 9p21.3 locus were in high LD with one another and localized within a region that is devoid of a single protein coding sequence. 5 This locus coincides with the ANRIL gene, a recently discovered antisense noncoding RNA postulated to enhance gene expression. 6, 19, 38 There are multiple neighboring protein coding genes in this region, including CDKN2A, CDKN2B, and MTAP, proposed to play important roles in cell cycle progression, cellular proliferation, apoptosis, and cellular senescence. 6, 39, 40 Although allelic frequencies for most variants and LD pattern at the 9p21.3 locus were similar in Pakistanis and Europeans, the odds ratios for CAD with most variants at this locus were lower in Pakistanis. There are previous reports of cardiometabolic diseases having differential genetic effects by ethnicity, such as stronger associations of an LTA4H haplotype with MI in Africans than Europeans 41 and TCF7L2 being relevant to type 2 diabetes mellitus in West Africans but not East Asians. 42 Nevertheless, further study is needed to determine whether the apparently different odds ratios for CAD with variants at Figure 2 . Association with MI in Pakistanis, Europeans, and East Asians for 12 variants genotyped in PROMIS. The odds ratios in PRO-MIS were computed using an additive model, adjusted for age, sex, and the first 2 principal components. Analyses for rs1333409, rs10757274, rs4977574, and rs2891168 are adjusted for age, sex, and self-reported ethnicity. Effect estimates in Europeans and East Asians are derived from literature-based meta-analyses. P-value het: The P value for heterogeneity corresponds to a heterogeneity test comparing effect estimates in the different ethnic groups. Individual plots for each meta-analysis are presented in supplemental Figure  6A through W. RAF indicates risk allele frequency (in controls).
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the 9p21.3 locus, noted in this study of Pakistanis versus Europeans, are true or mainly the result of nonethnic factors, such as differences in case definitions, age of disease onset, and epidemiological design. However, in the absence of ethnic mediated differences in disease susceptibility, the present Pakistani study might have been expected to yield higher odds ratios than most previous studies in Europeans because of likely enrichment for genetic signals (eg, through use of strict phenotyping and inclusion of early-onset firstever MI cases with a high degree of familial clustering). Therefore, such considerations reinforce the need for further studies of MI in Pakistanis to help validate and discover its population-relevant genetic determinants.
In conclusion, this study has provided the first demonstration that variants at the 9p21 locus are significantly associated with MI risk in Pakistanis. However, association signals at this locus were weaker in Pakistanis than those previously reported in Europeans.
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